Cal-Vantage®
Pilot Clinical Study Assessing the Impact on Bone Resorption
of The Dietary Supplement CalVantage®
A three-month clinical trial assessing the bone-building potential
of CalVantage, a unique vitamin/mineral and herbal formula.
The endpoints for this study are bone resorption at 6 and 12
weeks, blood pressure and weight. Our three-month trial is extended.
We found these results promising and have extended this study
for 1 year to look at the impact of Cal-Vantage® on Bone
Mineral Density in post-menopausal women. For details please read our study
report, Pilot Clinical Study Assessing the Impact on Bone Resorption and Bone Mineral Density of the Dietary Supplement Cal-Vantage™.
